Along with co-founder Brandon Kao, Rui Jing Jiang started Avisi Technologies in 2017, developing VisiPlate, a nanotechnology-enabled ocular implant to treat glaucoma. The University of Pennsylvania spinout has raised more than $3 million from groups like Ben Franklin Technology Partners, Quaker Capital and Life Science Angels. Avisi also recently snagged the Glaucoma Foundation’s H. Dunbar Hoskins International Innovation Award and the Octane Ophthalmology Technology Summit People’s Choice Award.